Metabolic activation of phenanthrene by human and mouse cytochromes P450 and pharmacokinetics in CYP1A2 knockout mice
- 18 September 2009
- journal article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 183 (1), 57-66
- https://doi.org/10.1016/j.cbi.2009.09.008
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Analysis of 51 persistent organic pollutants in soil by means of ultrasonic solvent extraction and stir bar sorptive extraction GC-MSJournal of Separation Science, 2008
- Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous SubstratesCancer Research, 2008
- Phenotype of theCyp1a1/1a2/1b1(-/-) Triple-Knockout MouseMolecular Pharmacology, 2008
- Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicityPharmacogenetics and Genomics, 2006
- FACS-optimized mutants of the green fluorescent protein (GFP)Gene, 1996
- Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450Cancer Letters, 1994
- cDNA Cloning, Sequence Analysis, and Induction by Aryl Hydrocarbons of a Murine Cytochrome P450 Gene,Cyp1b1DNA and Cell Biology, 1994
- Comparative metabolism of phenanthrene in the rat and guinea pigJournal of Environmental Science and Health, Part B, 1992
- Prostaglandin synthetase dependent activation of 7,8-dihydro-7,8-dihydroxy-benzo(a)pyrene to mutagenic derivativesBiochemical and Biophysical Research Communications, 1978
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973